Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Hypoglycemia Associated Autonomic Failure
NCT00678145Phase 2Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Mar 2008
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone, morphine, epinephrine in hypoglycemia-associated autonomic failure (HAAF), sponsored by Albert Einstein College of Medicine. Started Mar 2008; status: terminated.
02
Drugs
naloxonemorphineepinephrine
03
Conditions
hypoglycemia-associated autonomic failure (HAAF)
Beyond the preview
Go deeper on NCT00678145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678145.